Enteric Hyperoxaluria

Key Takeaways

The client was struggling to enroll a clinical trial evaluating an investigational therapy for enteric hyperoxaluria in patients who had previously undergone Roux-en-Y bariatric surgery — a common cause of the condition. This was the first in-human study for the investigational therapy.

Patients are not often aware they have enteric hyperoxaluria and don’t know it is associated with painful and recurring kidney stones. So, then, how do you interest and enroll patients in a clinical trial?

Drawing on in-depth research and prior experience recruiting patients with kidney stones, BBK Worldwide leveraged a bold strategy that prioritized the very real aspect of kidney stones. BBK made the connection between bariatric surgery and kidney stones clear for patients, creating awareness and interest in the study.